CEO goes Finance
09.04.2013 - Wellington Partners has appointed Stuart M. Essig as a new Venture Partner for its life sciences investment team.
Essig comes from global medical device company Integra LifeSciences Holdings Corporation where he was CEO and Chairman of the Board from 1997. Before joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a Managing Director. Mr. Essig brings ten years of broad health care experience at Goldman Sachs, serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. Mr. Essig also serves on the Board of Directors of St. Jude Medical Corporation and ADVAMED, the Advanced Medical Technology Association. Mr. Essig received an A.B. degree from the Woodrow Wilson School of Public and International Affairs at Princeton University and an M.B.A. and a Ph.D. degree in Financial Economics from the University of Chicago, Booth School of Business.http://www.european-biotechnology-news.com/people/bio-people/2013-01/stuart-m-essig.html